The industry landscape
Who is building what, from implanted BCIs to neuromodulation giants to consumer headbands to research hardware, what each hires for, and how to read the field's news without being fooled. Dated, and meant to be re-checked.
You are skimming: the title, the first figure, and the short version. Switch to Read in the header for the full page, or Deep to open every deep dive.
The field has five kinds of companies, they hire for different spines, and they are at very different stages. Knowing which is which lets you read a headline (“company X implants first patient”) and know whether it is a milestone or a press release, and lets you aim your portfolio at the kind of company that will want it.
Implanted BCI companies
Venture-funded, pre-revenue, running early feasibility trials under IDEs, all aiming at paralysis and speech first. Blackrock Neurotech (Salt Lake City): the Utah Array, the most human implants of anyone, a Breakthrough-designated system. Neuralink: flexible threads, a robotic inserter, a sealed skull-mounted can, human trials since 2024, the largest funding. Synchron: the stentrode, delivered through the jugular vein, the least invasive approach, human trials for years. Paradromics: very high channel counts on many small stiff electrodes, aimed at speech. Precision Neuroscience: thin-film surface arrays placed through a slit, reversible. Science Corp: retinal prosthesis and other programs.
They hire: analog and mixed-signal designers, firmware and embedded engineers, packaging and materials engineers, decoder and machine-learning engineers, clinical and regulatory staff, and neurosurgical liaisons. Undergraduate internships exist but are few; a characterized board and a reproduced decoder are the entry ticket. Read their job pages to see which spines they are short of this year.
Neuromodulation companies
Established, profitable, regulated, large. Medtronic, Boston Scientific, Abbott (DBS, spinal cord stimulation, sensing-capable generators). LivaNova (vagus nerve stimulation). Nevro (high-frequency spinal cord stimulation). NeuroPace (responsive neurostimulation for epilepsy). Cochlear, MED-EL, Advanced Bionics (cochlear implants). Insightec (focused ultrasound). Neuronetics, BrainsWay (TMS).
They hire: every engineering discipline, at scale, plus quality, regulatory, clinical, and field engineers who program devices in clinics. This is where most of the jobs are and where a co-op or internship is most attainable. The clinical-regulatory spine is valued here more than anywhere.
Non-invasive and consumer
Emotiv, Muse (Interaxon), Neurable, Kernel (TD-fNIRS at research grade), sleep-wearable companies, and a steady stream of startups. Products range from research-adjacent headsets to wellness bands. Business models are hard: the signals are limited, the wellness claims are constrained, and many devices end up in drawers. Meta’s EMG wristband (from the CTRL-labs acquisition) is the peripheral bet with the most resources behind it.
They hire: embedded and signal-processing engineers, product designers, machine-learning engineers, and increasingly human-factors people. Startups here will trade title and equity for skill; being an early engineer at one at nineteen teaches more than a class.
Research hardware
Ripple Neuro (Salt Lake City): recording and stimulation systems for research and implants in development. Intan Technologies: the amplifier chips inside many headstages. Open Ephys: open-source acquisition. IMEC and the Neuropixels program. BrainProducts, g.tec, ANT Neuro, Biosemi: research EEG systems. OpenBCI.
They hire: exactly the Phase 2 skills. A student with a characterized ADS1299 board is speaking their language.
The rehabilitation and assistive sector
Ottobock, Össur, Coapt (myoelectric prostheses and pattern-recognition control), Ekso, ReWalk (exoskeletons), MicroTransponder (VNS for stroke), Onward (spinal cord stimulation for injury), plus the AAC companies (Tobii Dynavox). Smaller, closer to patients, and where Phase 5 skills go directly.
A headline reads: 'Startup implants first human patient with brain chip.' What does this most likely mean about where the company is?
An early feasibility study has begun. First-in-human is a real milestone (it means the FDA allowed the study and a surgeon agreed), and it is also the beginning of a path that runs through more participants, a pivotal trial, a PMA, and a reimbursement decision, typically a decade. Reading neurotech news well means mapping each headline onto the regulatory pathway page.
Reading the field
Sources that are worth the time: the companies’ own published papers (not their press), the FDA’s databases, the BCI Society and NeurotechX communities, Neurotech Reports and similar trade newsletters, and the journals in the reading thread. Sources that are not: most general press coverage of “mind reading,” which conflates decoding attempted speech from motor cortex with reading thoughts.
Utah, again
Two of the research-hardware and implant companies above are in Salt Lake City. Nelson Labs and other test houses that certify devices are in the corridor. BioUtah’s member list is a directory of every device company in the state, many of which hire BME students for quality, test, and R&D roles, and few of which BME students know exist. The Utah map is the local version of this page.
Explain what this page was about to your roommate in three sentences. No jargon they would not know.